Clinical Trials
10 trialsNCT01384513 2026-04-15
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Phase 2 Completed
NCT00255346 2025-12-30
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05323188 2025-09-12
KID-Tryp
Assistance Publique - Hôpitaux de Paris
Completed
NCT00038675 2022-01-04
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
M.D. Anderson Cancer Center
Phase NA Completed
NCT02503800 2019-08-20
The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy
Meir Medical Center
Completed
NCT00336076 2016-11-07
Molecular Mechanisms and Diagnosis of Mastocytosis
University of Michigan
Completed
NCT01481909 2016-11-03
SMART
Charite University, Berlin, Germany
Phase 2/3 Completed
NCT01297777 2016-08-29
Imatinib in KIT-negative Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 4 Completed
NCT01333293 2016-01-18
XOLMA
University of Zurich
Phase 2/3 Completed
NCT00467792 2008-12-08
UP
Medical College of Wisconsin
Completed